Hogan Lovells is a sponsor of the PCF International Pharma Congress, which brings together senior global compliance professionals and legal counsel from around the world to share experiences and best practices to clarify these changes and potential responses to them. In Europe, regulators are increasingly active at both national and European levels. In the USA, the newly revised PhRMA codes and the new Obama administration are beginning to have a significant impact across the pharmaceutical industry. In Asia, governments are bringing in new legislation and/or enforcing existing legislation to dispel perceptions of corruption and/or conflicts of interest within the public sector.
A number of Hogan Lovells lawyers are speaking on various topics of interest during the Pharma Congress. To view the program, visit the PCF International Pharma Congress website.